Medtronic Receives the US FDA's Approval for its Percept PC Neurostimulator with BrainSense Technology
Shots:
- Percept is the first and only DBS neurostimulation system with BrainSens technology- allowing it to capture brain signals while delivering therapy to patients with neurologic disorders associated with Parkinson’s disease- essential tremor- dystonia- epilepsy- and OCD
- Percept PC DBS system features 3T and 1.5T full-body MRI scans- smart battery and low pulse width and has received CE mark in Jan’2020
- Mayo Clinic will be the first to implant the Medtronic’s DBS system in the US. DBS is an individualized therapy delivered from a small pacemaker-like device- placed under the skin of the chest or abdomen- to send electrical signals through leads to a targeted area in the brain related to the symptoms of a neurological disorder
Click here to read full press release/ article | Ref: Medtronic | Image: Medtronic
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com